United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Healthcare Industry News Know Labs faces legal scrutiny over Goldeneye merger as shareholder rights come into focus Halper Sadeh LLC is investigating Know Labs' proposed sale to Goldeneye 1995 LLC. Shareholders may be entitled to legal remedies or enhanced disclosures. byPallavi MadhirajuJune 7, 2025